Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 440-550-2 | CAS number: 244021-01-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- short-term repeated dose toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2007 / 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: Performed accoring to OECD and EEC-guidelines under GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 407 (Repeated Dose 28-Day Oral Toxicity Study in Rodents)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
Test material
- Details on test material:
- Identification: TKA 40270 (CGPS 345)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals: Rat, HanRcc: WIST(SPF)
Rationale: Recognized by international guidelines as a recommended rodent test system.
Breeder: RCC Ltd
Laboratory Animal Services
Wölferstrasse 4
4414 Füllinsdorf / Switzerland
Number of Animals: Group 1: 10 males and 10 females
Group 2: 5 males and 5 females
Group 3: 5 males and 5 females
Group 4: 10 males and 10 females
Reserve animals:
Group 10: 1 male and 1 female
These were removed from the study during the
acclimatization period.
Age (at Delivery): Ca. 7 weeks
Body Weight Range
(at Acclimatization): Males: 178 to 206 g (mean 196 g)
Females: 130 to 148 g (mean 140 g)
Identification: Cage card and individual animal number (ear tattoo).
Acclimatization: Under test conditions after health examination. Only
animals without any visible signs of illness were
used.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- TKA 40270 (CGPS 345) was administered daily by oral gavage to SPF-bred Wistar rats of both sexes at dose levels of 60, 200 and 600 mg/kg body
weight/day for a period of 28 days. A control group was treated similarly with the vehicle, corn oil, only. A
dose volume of 5 mL/kg was administered.
- Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Several application formulations were prepared and representative analytical samples were
collected and dispatched to the analytical laboratories internally. The test item concentrations
were determined by HPLC coupled to an UV detector and quantified with the area under the
peak. - Duration of treatment / exposure:
- 28 days
- Frequency of treatment:
- Daily
Doses / concentrations
- Remarks:
- Doses / Concentrations:
60, 200 and 600 mg/kg body weight/day for a period of 28 days.
Basis:
other: nominal in corn oil
- No. of animals per sex per dose:
- Number of Animals:
Group 1 (control): 10 males and 10 females
Group 2 (60 mg/kg/day): 5 males and 5 females
Group 3 (200 mg/kg/day): 5 males and 5 females
Group 4 (600 mg/kg/day): 10 males and 10 females - Control animals:
- yes, concurrent vehicle
- Details on study design:
- The test substance was administered daily by oral gavage to SPF-bred Wistar rats of both sexes at
dose levels of 60, 200 and 600 mg/kg body weight/day for a period of 28 days.
A control group was treated similarly with the vehicle, corn oil, only.
A dose volume of 5 mL/kg was administered.
The groups comprised 5 animals per sex which were sacrificed after 28 days of treatment.
Additional 5 rats per sex and group were used at 0 and 600 mg/kg. These animals were treated
for 28 days and then allowed a 14-day treatment-free recovery period after which they were
sacrificed.
Clinical signs, outside cage observation, food consumption and body weights were recorded
periodically during pretest, the treatment and recovery periods. Functional observational battery,
locomotor activity and grip strength were performed during week 4.
At the end of the dosing and the treatment-free recovery period, blood samples were withdrawn
for hematology and plasma chemistry analyses. Urine samples were collected for urinalyses. All
animals were killed, necropsied and examined post mortem. Histological examinations were
performed on organs and tissues from all control and high dose animals, and all gross lesions
from all animals.
From the animals of the low and middle dose groups, the livers, spleens and thyroid glands were
examined to establish a no-effect level. - Positive control:
- No
Examinations
- Observations and examinations performed and frequency:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Daily
- Cage side observations checked in table [No.?] were included.
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: day 4 to 28
BODY WEIGHT: Yes
- Time schedule for examinations: Before treatment, day 4, and 15 to 28
FOOD CONSUMPTION AND COMPOUND INTAKE :
- Food consumption for each animal determined and mean daily diet consumption calculated as g food/kg body weight/day: Yes
- Compound intake calculated as time-weighted averages from the consumption and body weight gain data: Yes
FOOD EFFICIENCY:
- Body weight gain in kg/food consumption in kg per unit time X 100 calculated as time-weighted averages from the consumption and body weight
gain data: Yes
WATER CONSUMPTION AND COMPOUND INTAKE (if drinking water study): Yes
- Time schedule for examinations: day 4 to 8
OPHTHALMOSCOPIC EXAMINATION: Yes
- Time schedule for examinations: 28 day
- Dose groups that were examined: No test item-related changes of toxicological relevance were noted at any dose leve
HAEMATOLOGY: Yes
- Time schedule for collection of blood: daily
- Anaesthetic used for blood collection: Yes (identity)
- Animals fasted: No data
- How many animals: 5 per sex per group
CLINICAL CHEMISTRY: Yes
- Time schedule for collection of blood:
- Animals fasted: No data
URINALYSIS: Yes
- Time schedule for collection of urine:
- Metabolism cages used for collection of urine: Yes
NEUROBEHAVIOURAL EXAMINATION: Yes
- Time schedule for examinations:
- Dose groups that were examined:
- Battery of functions tested: grip strength
- Sacrifice and pathology:
- Histological examinations were performed on organs and tissues from all control and high dose animals, and all gross lesions
from all animals.
From the animals of the low and middle dose groups, the livers, spleens and thyroid glands were
examined to establish a no-effect level.
Results and discussion
Results of examinations
- Clinical signs:
- no effects observed
- Mortality:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Food efficiency:
- no effects observed
- Water consumption and compound intake (if drinking water study):
- no effects observed
- Ophthalmological findings:
- no effects observed
- Haematological findings:
- no effects observed
- Clinical biochemistry findings:
- no effects observed
- Urinalysis findings:
- no effects observed
- Behaviour (functional findings):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Gross pathological findings:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Histopathological findings: neoplastic:
- no effects observed
- Details on results:
- Oral administration of TKA 40270 (CGPS 345) to Wistar rats at doses of 60, 200 and
600 mg/kg/day, for 28 days did not induce test item-related deaths nor relevant clinical signs
during daily and weekly observations. The functional observational battery (week 4) did not
reveal any relevant changes. Food consumption was unaffected and no test item-related changes
of toxicological relevance in the hematology or urinalysis parameters at any dose level.
Test item-related reductions in the body weight development were seen in both sexes treated
with 200 mg/kg/day and 600 mg/kg/day. Changes in clinical biochemistry parameters, indicative
of changes in liver metabolism, were considered to be largely metabolic and adaptive in nature,
and were largely reversible by the end of the recovery period.
These findings were evident in females at 200 mg/kg/day and both sexes at 600 mg/kg/day and
correlated with organ weight changes and histopathological findings in the liver. Liver weight
changes were seen in males and females at all dose levels, and macroscopically observed liver
enlargement was associated with increased centrilobular hepatocellular hypertrophy. This latter
liver finding, minimal in severity, was noted in only two males at the end of the 2-week recovery
period, which was considered to be indicative of reversibility.
Kidney weights were increased in males at 200 mg/kg/day and 600 mg/kg/day without any
relevant histopathological correlate.
Furthermore, increased extramedullary hemopoiesis in the spleen and increased follicular cell
hypertrophy in the thyroid gland were observed in males and females treated at 200 and
600 mg/kg/day and were largely reversible after the recovery period.
Based on the results of this study, the no-observed-effect-level (NOEL) was below the lowest dose tested (60 mg/kg/day). However, considering the nature and reversibility of the findings noted, the no-observed-adverse-effect-level (NOAEL) was established at 600 mg/kg body weight/day.
.
Effect levels
- Dose descriptor:
- NOAEL
- Effect level:
- 600 mg/kg bw/day (actual dose received)
- Sex:
- male/female
- Basis for effect level:
- other: liver effects
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Iako ECHA većinu materijala na ovim stranicama osigurava na vašem jeziku, dio ove stranice samo je na engleskom. Dodatne informacije o politici višejezičnosti ECHA-e.
Dobro došli na stranice ECHA-e Ove stranice ne podržavaju potpuno Internet Explorer 7 (i njegove ranije inačice). Preuzmite noviju inačicu Internet Explorera.
Na ovom portalu koristimo kolačiće kako bismo vam osigurali najbolje iskustvo njegova pregledavanja.
Saznajte više o tome kako upotrebljavamo kolačiće.